Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study.
about
Treatment of early uterine sarcomas: disentangling adjuvant modalitiesAdjuvant treatment after hysterectomy for uterine leiomyosarcomaCurrent Chemotherapy and Potential New Targets in Uterine LeiomyosarcomaPractice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology Consensus StatementUK guidelines for the management of soft tissue sarcomasUterine fibroids: current perspectivesUnusual indolent behavior of leiomyosarcoma of the vagina: Is observation a viable option?Treatment of hormone positive uterine leiomyosarcoma with aromatase inhibitors.Pulmonary toxicity among cancer patients treated with a combination of docetaxel and gemcitabine: a meta-analysis of clinical trials.Unusually young age distribution of primary hepatic leiomyosarcoma: case series and review of the adult literatureClinical practice guidelines for the diagnosis and treatment of patients with soft tissue sarcoma by the Spanish group for research in sarcomas (GEIS).Constitutive activation with overexpression of the mTORC2-phospholipase D1 pathway in uterine leiomyosarcoma and STUMP: morphoproteomic analysis with therapeutic implications.Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: results of a phase 2 trial (SARC 005).Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Uterine sarcoma. Clinico-pathological characteristics and outcome.A phase II trial to assess the activity of gemcitabine and docetaxel as first line chemotherapy treatment in patients with unresectable leiomyosarcoma.Extragenital adenosarcoma: a case report, review of the literature, and management discussion.Long Term Prognostic Implications of Expression of Glucose Transporter-1 and Hexokinase II in Patients with Stage I Uterine Leiomyosarcoma.Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015).Clinical Characteristics, Surgical Management and Adjuvant Therapy of Patients with Uterine Leiomyosarcoma: 27 Years of ExperienceThe role of adjuvant therapy in uterine leiomyosarcomaA nomogram to predict postresection 5-year overall survival for patients with uterine leiomyosarcoma.Treatment of advanced uterine leiomyosarcoma with aromatase inhibitorsImproved clinical trial enrollments for uterine leiomyosarcoma patients after gynecologic oncology partnership with a sarcoma centerDasatinib (BMS-35482) potentiates the activity of gemcitabine and docetaxel in uterine leiomyosarcoma cell lines.A small-molecule inhibitor targeting the mitotic spindle checkpoint impairs the growth of uterine leiomyosarcoma.Feasibility and efficacy of gemcitabine and docetaxel combination chemotherapy for bone and soft tissue sarcomas: multi-institutional retrospective analysis of 134 patients.Role of chemotherapy in the management of soft tissue sarcomas.Histology-driven chemotherapy in soft tissue sarcomas.Treating soft tissue sarcomas with adjuvant chemotherapy.Current management of uterine sarcomas.Diagnosis and management of leiomyosarcoma arising from ovarian vein: case report and literature review.A review of treatment of uterine leiomyosarcomas.Pharmacological treatment for uterine leiomyosarcomas.The indications and efficacy of conventional chemotherapy in primary and recurrent sarcoma.Gastrointestinal (GI) leiomyosarcoma (LMS) case series and review on diagnosis, management, and prognosis.Current Status of Uterine Leiomyosarcoma in the Tohoku Region: Results of the Tohoku Translational Center Development Network Survey.Uterine leiomyosarcoma: a review of recent advances in molecular biology, clinical management and outcome.Looking for answers: the current status of neoadjuvant treatment in localized soft tissue sarcomas.Comparison of polyvinyl alcohol and tris-acryl gelatin microsphere materials in embolization for symptomatic leiomyomas: a systematic review.
P2860
Q21245577-4BD79503-C72C-412C-8AD6-0985E905918AQ24187806-BA5AABB3-9FE8-4144-82C2-BB418E047963Q26767435-58B58737-C46A-4953-A17B-A4957B80855BQ28069514-0C9677EC-F2C8-4F5A-934A-98BC7B7D7C3FQ28076730-B94AFCC4-D359-4F33-BDD8-322EE104A8D3Q30443242-0FD56243-ED89-4DA7-9E0E-1CD46E6E83A5Q33802851-3114FDC6-6A0A-414E-A715-D44797DEE4F5Q33890085-1A38CAFA-6F94-4DD3-9AC4-8A7E438143C3Q33891037-14F7DD87-8C44-4301-A073-7BD216DAFA03Q33986704-14AA6900-32C9-4D34-8B56-A3807837B27CQ34045393-90ACC5AC-225F-4C28-B045-A160A0249C9EQ34566745-7A1F0EC2-8A46-42E2-9055-6828C616A8F6Q34647409-970C41BF-BD92-4BE7-BA8F-432F5A19BDC7Q34664479-45CE5757-8B8C-4EE9-BC66-C727DDFA1445Q35183504-70A3CF96-8D57-4D68-A0FA-FA91914234DEQ35616803-2A8CBB5E-C9E7-4F58-AE34-3584A63B1EC3Q35671534-773B7FE1-1CD2-4149-B21D-F871D6F07F55Q36001482-0948EAC9-894C-48EF-BDCA-BC3E32FC6672Q36295510-77C043F6-6E44-40B4-9FBA-AA9659FE2688Q36743296-D2238CEC-5B8B-4E03-8D3E-8E2DD3E32420Q36811788-1F9CFDD6-21ED-4601-9A3C-3078ACFDA9D0Q36826881-0E709C9C-36EE-480A-898C-6361DC144A98Q36855589-9811A76B-26AF-4714-BDD0-EAFBC80692D3Q36883521-22314402-B0F1-4A45-A184-CC19C0A22474Q36929175-98B8183F-F0A2-48F0-BDB9-2C278CACD9DAQ37296303-83051FC4-9222-42CA-85A0-C43E0571C4F0Q37487765-25882867-874A-4B2B-A79C-0A289B7D5210Q37687389-4F02CB2E-FC21-42EF-B103-6F510BA2A915Q37848174-0632E633-D932-4C12-A404-90F5EE7190AFQ37850703-2611D3FE-C47E-4C10-A75D-074FAB8C3936Q37877412-870E4A70-1BBB-4726-B445-A71E48A6D534Q37974320-1490EA06-8C8C-4D28-9D9A-782B5D174534Q38153648-7513F210-7946-41FD-96DC-90E4005DEB2CQ38270671-F65250EC-1DA9-4B6B-968C-CF60DCFF61BFQ38315670-20AFC894-ED9A-469F-A042-F143F1E20AABQ38703103-289521AE-869C-48ED-B006-8CA448D0FBE6Q38758661-597F58E5-BB06-4BFA-9987-36710CB009CDQ38765107-306B3674-9566-4B80-99DD-ED1193E552E0Q38840133-E066C53D-EDAB-4E31-8D58-B73023A3A385Q38902066-B71F45F7-166E-489F-9A8D-9FD7109EE1BA
P2860
Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Adjuvant gemcitabine plus doce ...... esults of a prospective study.
@en
Adjuvant gemcitabine plus doce ...... esults of a prospective study.
@nl
type
label
Adjuvant gemcitabine plus doce ...... esults of a prospective study.
@en
Adjuvant gemcitabine plus doce ...... esults of a prospective study.
@nl
prefLabel
Adjuvant gemcitabine plus doce ...... esults of a prospective study.
@en
Adjuvant gemcitabine plus doce ...... esults of a prospective study.
@nl
P2093
P1433
P1476
Adjuvant gemcitabine plus doce ...... esults of a prospective study.
@en
P2093
Carol A Aghajanian
David Spriggs
Joseph Larkin
Martee L Hensley
Nadeem Abu-Rustum
Nicole Ishill
Paul Sabbatini
William Tew
P304
P356
10.1016/J.YGYNO.2008.11.027
P407
P577
2009-01-09T00:00:00Z